---
title: "Growth is the \"Achilles' heel\" for India's Life Insurance Corp, analysts say"
date: "2025-02-10 13:18:50"
summary: "** Growth the Achilles' heel for Life Insurance Corp of India , Emkay says** Insurer's annual premium equivalent (APE), a measure of new business sales growth, down 24% in Q3** LIC trying to grow APE by increasing policy sales volumes and ticket sizes, analysts say** Emkay slashes APE estimates by..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Growth the Achilles' heel for Life Insurance Corp of India , Emkay says

\*\* Insurer's annual premium equivalent (APE), a measure of new business sales growth, down 24% in Q3

\*\* LIC trying to grow APE by increasing policy sales volumes and ticket sizes, analysts say

\*\* Emkay slashes APE estimates by ~6% for FY25-FY27, Centrum by 4% for the same period

\*\* Co able to maintain margins by increasing share of more profitable policies in overall product mix despite new regulations that reduce cost for policymakers to surrender policies before maturity, analysts say

\*\* Stock trading flat

\*\* LIC is rated 'buy' on avg by 19 analysts; avg PT of 1168 rupees implies a ~42% upside to current price, according to data compiled by LSEG

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P10CM:0-growth-is-the-achilles-heel-for-india-s-life-insurance-corp-analysts-say/)
